Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ault Glazer Capital Partners is a private investment firm that focuses on the life sciences, biotechnology, and healthcare sectors. The firm specializes in identifying undervalued assets and providing the necessary capital and strategic guidance to bring innovative medical solutions to market. Led by Milton "Todd" Ault III and William B. Glazer, the firm often takes significant positions in emerging companies, such as those developing treatments for Alzheimer's disease and infectious diseases. Their approach combines financial expertise with active management to drive the growth of their portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ault Glazer Capital Partners.